English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduUMass Amherst researcher co-leads worldwide efforts to understand how genetic variants are linked with disease to develop new drugs and treatments.
Tag: Complications
Artificial intelligence may help predict infection risks after implant-based breast reconstruction
Artificial intelligence (AI) techniques may provide a more accurate approach to predicting the risk of periprosthetic infection after implant-based breast reconstruction, reports a study in the November issue of Plastic and Reconstructive Surgery®, the official medical journal of the American Society of Plastic Surgeons (ASPS).
Higher patient satisfaction after breast reconstruction using patients’ own tissues
Women undergoing autologous breast reconstruction – in which the breast is reconstructed using the patient’s own tissues.
For Children With Cancer, Different Neighborhoods May Produce Different Outcomes for Different Races
A Rutgers study links zip code and cancer complication disparities in pediatric patients.
Mount Sinai Study Identifies Significant Inequalities Among Low-Risk Births, Finds Higher Rates of Unexpected Complications for Black and Hispanic Infants
Hospital quality of care during delivery is a major factor for racial and ethnic disparities among low-risk newborns
Dermatologists warn consumers about the dangers of buying cosmetic injectables — such as fillers — online
A new article published online in the Journal of the American Academy of Dermatology reveals just how common these illicit products are on popular e-commerce sites, increasing the public’s risk for severe and potentially long-term complications, including blindness, disfiguration, and stroke.
New Closed-Loop System Offers Promise as Novel Treatment for Post-Bariatric Hypoglycemia
Post-bariatric hypoglycemia is a profoundly life-altering condition for patients. Having unpredictable hypoglycemia that people can’t detect is really an unsafe situation. Researchers at Joslin Diabetes Center and Harvard John A. Paulson School of Engineering and Applied Sciences have developed a closed-loop system that automatically provides patients with an appropriate, as-needed dose of liquid glucagon to treat this condition.